a<p>Incidence of clinical episodes (episodes per person-year) in the absence of intervention at an EIR of 20 ibpa.</p>b<p>Incidence of mortality (malaria-related deaths per 100,000 person-years) in the absence of intervention at an EIR of 20 ibpa.</p>c<p>Proportion of clinical episodes that are averted during the first 10 y of a mass vaccination program.</p>d<p>These parameters were fixed; in other models the decay parameters were estimated. Decays shorter than the shortest fixed values gave unacceptable fits to the data.</p><p>s.d., standard deviation.</p
<p>(A) These line curves show the cumulative distributions of the durations of infection for the mal...
<p>Parameter estimates for the four census sites, obtained from the model (cf. <a href="http://www....
<p><b>A</b> Predicted probability distribution of the final number of cases (blue) and deaths (red) ...
<p>(A) EIR = 2 ibpa, no intervention. (B) EIR = 20 ibpa, no intervention. (C) EIR = 2 ibpa, EPI vacc...
<p>(A) EIR = 2 ibpa, EPI vaccination. (B) EIR = 20 ibpa, EPI vaccination. (C) EIR = 2 ibpa, EPI and ...
<p>* In sensitivity analysis we keep the relationship θ = 1000*μ to maintain a steady population siz...
Several aspects of treatment disruptions were simulated in a factorial manner, including duration of...
<p>Each bar in the chart represents an average across 30 simulation runs for a given parameter setti...
<p>*New parameters in the model (also described in the main text); all others are as reported in Mar...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
, and have been calibrated for such settings. Their applicability to low transmission settings is un...
<p>The model fit and outcomes (post-vaccination prevalence) under different model assumptions about ...
<p>(A) EIR = 2 ibpa, EPI vaccination. (B) EIR = 20 ibpa, EPI vaccination. (C) EIR = 2 ibpa, EPI and ...
<p>Univariate sensitivity analysis for parameters <i>E</i><sub><i>S</i></sub>, <i>E</i><sub><i>H</i>...
<p>(A) These line curves show the cumulative distributions of the durations of infection for the mal...
<p>Parameter estimates for the four census sites, obtained from the model (cf. <a href="http://www....
<p><b>A</b> Predicted probability distribution of the final number of cases (blue) and deaths (red) ...
<p>(A) EIR = 2 ibpa, no intervention. (B) EIR = 20 ibpa, no intervention. (C) EIR = 2 ibpa, EPI vacc...
<p>(A) EIR = 2 ibpa, EPI vaccination. (B) EIR = 20 ibpa, EPI vaccination. (C) EIR = 2 ibpa, EPI and ...
<p>* In sensitivity analysis we keep the relationship θ = 1000*μ to maintain a steady population siz...
Several aspects of treatment disruptions were simulated in a factorial manner, including duration of...
<p>Each bar in the chart represents an average across 30 simulation runs for a given parameter setti...
<p>*New parameters in the model (also described in the main text); all others are as reported in Mar...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
, and have been calibrated for such settings. Their applicability to low transmission settings is un...
<p>The model fit and outcomes (post-vaccination prevalence) under different model assumptions about ...
<p>(A) EIR = 2 ibpa, EPI vaccination. (B) EIR = 20 ibpa, EPI vaccination. (C) EIR = 2 ibpa, EPI and ...
<p>Univariate sensitivity analysis for parameters <i>E</i><sub><i>S</i></sub>, <i>E</i><sub><i>H</i>...
<p>(A) These line curves show the cumulative distributions of the durations of infection for the mal...
<p>Parameter estimates for the four census sites, obtained from the model (cf. <a href="http://www....
<p><b>A</b> Predicted probability distribution of the final number of cases (blue) and deaths (red) ...